CANCER TREATMENT USING CHIMERIC ANTIGEN-SPECIFIC RECEPTOR BASED ON HUMANISED ANTI-EGFRvIII ANTIBODY Russian patent published in 2019 - IPC C07K16/28 C07K19/00 A61K35/17 A61K39/44 C12N15/13 C12N15/63 C12N5/10 A61P35/00 C12N5/783 

Abstract RU 2708032 C2

FIELD: medicine.

SUBSTANCE: present invention relates to immunology. Disclosed is a binding domain against EGFRvIII, comprising a chimeric antigenic receptor encoding nucleic acids, a vector, a cell, as well as use of said inventions in the manufacture of a medicament, methods of producing a cell and obtaining a population of cells, a method for providing immunity, a method of treating.

EFFECT: present invention can find further application in therapy using adaptive cell transfer.

103 cl, 18 dwg, 9 ex, 2 tbl

Similar patents RU2708032C2

Title Year Author Number
TREATING CANCER BY HUMANISED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR 2014
  • Brogdon Dzhennifer
  • Dzhun Karl Kh.
  • Lev Andreas
  • Maus Marsela
  • Sholler Dzhon
RU2711975C2
CHIMERIC HUMAN MESOTHELIOGEN ANTIGEN RECEPTORS AND USE THEREOF 2014
  • Bitti Gregori
  • Engels Boris
  • Idamakanti Neeradzha
  • Dzhun Karl Kh.
  • Lev Andreas
  • Sun Khuejtszyuan
  • U Tsilun
RU2714902C2
CANCER TREATMENT WITH CHIMERIC CD33 ANTIGEN RECEPTOR 2015
  • Brogdon Jennifer
  • Ebersbach Hilmar
  • Gill Saar
  • Glass David
  • Huber Thomas
  • Jascur Julia
  • Kenderian Saad
  • Mannick Joan
  • Milone Michael C.
  • Murphy Leon
  • Richardson Celeste
  • Singh Reshma
  • Song Huijuan
  • Wu Qilong
  • Zhang Jiquan
RU2747384C2
CHIMERIC ANTIGEN RECEPTORS FOR CANCER TREATMENT 2017
  • Brannetti, Barbara
  • Brogdon, Dzhennifer
  • Engels, Boris
  • Granda, Brajan
  • Khuan, Lu
  • Lej, Min
  • Li, Na
  • Chzhan, Tszimin
  • Gimares, Karla
  • Dzhill, Saar
  • Ruella, Marko
  • Yang, Regina M.
RU2826270C2
TREATING A MALIGNANT TUMOR USING A CHIMERIC ANTIGEN CD19 RECEPTOR 2015
  • Brogdon, Jennifer
  • Byrd, John
  • Dubovsky, Jason
  • Fraietta, Joseph
  • Gill, Saar
  • Glass, David
  • Johnson, Amy
  • June, Carl, H.
  • Kenderian, Saad
  • Mannick, Joan
  • Maus, Marcela
  • Murphy, Leon
  • Muthusamy, Natarajan
  • Porter, David L.
  • Ruella, Marco
  • Sellers, William Raj
  • Wasik, Mariusz
RU2718542C2
CHIMERIC ANTIGENIC (CAR) RECEPTOR AGAINST CD123 FOR USE IN TREATING MALIGNANT TUMORS 2015
  • Brogdon, Jennifer
  • Gill, Saar
  • Glass, David
  • Kenderian, Saad
  • Loew, Andreas
  • Mannick, Joan
  • Milone, Michael
  • Murphy, Leon
  • Porter, David, L.
  • Ruella, Marco
  • Wang, Yongqiang
  • Wu, Qilong
  • Zhang, Jiquan
RU2724999C2
CHIMERIC ANTIGEN RECEPTORS AND THEIR PRODUCTION METHODS 2015
  • Kuper Lourens Dzh. N.
  • Korngold Ana Beatrits
  • Rabinovich Brajan A.
  • Singkh Khardzheet
  • Olivares Sajmon
RU2753965C2
TREATING CANCER USING A CHIMERIC ANTIGENIC CLL-1 RECEPTOR 2015
  • Brogdon, Jennifer
  • Ebersbach, Hilmar
  • Gill, Saar
  • Glass, David
  • Jascur, Julia
  • Kenderian, Saad
  • Mannick, Joan
  • Milone, Michael, C.
  • Murphy, Leon
  • Richardson, Celeste
  • Singh, Reshma
  • Wei, Lai
  • Wu, Qilong
  • Yang, Qiumei
  • Zhang, Jiquan
RU2741120C2
GLYCAN-DEPENDENT IMMUNOTHERAPY MOLECULES 2016
  • Demetriou Majkl
  • Chzhou Rejmond Venkhou
RU2754661C2
TYPES OF COMBINATION THERAPY USING CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBITORS 2017
  • Anak, Ozlem
  • Bajlik, Sejnela
  • Brogdon, Dzhennifer
  • Kemeron, Dzhon, Skott
  • Chou, Uillyam
  • Khauard, Denni, Roland, Ml.
  • Isaaks, Randi
  • Dzhun, Karl, Kh.
  • Lejsi, Sajmon
  • Mod, Shennon
  • Milenkhorst, Yan, Dzh.
  • Shaster, Stiven
  • Kintas-Kardama, Alfonso
  • Grapp, Stefan
  • Bitter, Khans
RU2809160C2

RU 2 708 032 C2

Authors

Brogdon Dzhennifer

Dzhonson Laura Aleksandra

Dzhun Karl Kh.

Lev Andreas

Maus Marsela

Sholler Dzhon

Okada Khidekho

Dates

2019-12-03Published

2014-02-20Filed